Elevated expression of IRAK1 has been reported in a variety of tumors, including lung cancer [41], endometrial carcinoma [42], and HCC [10], and has been identified to be correlated with tumor aggressive and poor patient prognosis. This evidence concerns the gene IRAK1 and hepatocellular carcinoma.